Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gallbladder01:17

Gallbladder

2.0K
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
2.0K
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

2.2K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

2.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of ABCG2 dysfunction on hyperuricemia progression in premenopausal and postmenopausal women.

Human cell·2026
Same author

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD).

Annals of the rheumatic diseases·2026
Same author

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

NPJ Parkinson's disease·2026
Same author

Genome-wide association study of copy number variations in Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Diuretic-Induced Hypomagnesemia May Play a Key Role in the Development of Calcium Pyrophosphate Arthritis.

Rheumatology and therapy·2026
Same author

SLC52A1 is a neofunctionalized primate urate transporter enabling intestinal urate secretion.

The Journal of biological chemistry·2026

Related Experiment Video

Updated: Jan 19, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.6K

Gout.

Nicola Dalbeth1, Hyon K Choi2, Leo A B Joosten3

  • 1Department of Medicine, University of Auckland, Auckland, New Zealand. n.dalbeth@auckland.ac.nz.

Nature Reviews. Disease Primers
|September 28, 2019
PubMed
Summary
This summary is machine-generated.

Gout is a chronic inflammatory disease caused by monosodium urate (MSU) crystal deposition. Effective management involves lowering serum urate levels and utilizing anti-inflammatory therapies, with nurse-led strategies improving patient outcomes.

More Related Videos

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.4K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Related Experiment Videos

Last Updated: Jan 19, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.6K
Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

4.4K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Area of Science:

  • Rheumatology
  • Immunology
  • Metabolic Disorders

Background:

  • Gout is a chronic inflammatory arthritis resulting from monosodium urate (MSU) crystal deposition.
  • Hyperuricemia, elevated serum urate levels, is the primary risk factor, influenced by both purine metabolism and altered urate transport.
  • Acute gout flares involve NLRP3 inflammasome activation and interleukin-1 beta (IL-1β) release.

Purpose of the Study:

  • To provide a comprehensive overview of gout pathogenesis, treatment strategies, and management best practices.
  • To highlight the role of urate-lowering therapy in long-term gout management.
  • To emphasize the importance of patient engagement and education in improving clinical outcomes.

Main Methods:

  • Review of current understanding of gout pathophysiology, including crystal deposition and inflammatory pathways.
  • Analysis of established and emerging therapeutic approaches for gout flares and chronic management.
  • Evaluation of care models, focusing on patient-centered strategies and their impact on outcomes.

Main Results:

  • Anti-inflammatory agents (corticosteroids, NSAIDs, colchicine) and anti-IL-1β therapies are effective for acute flares.
  • Sustained reduction of serum urate levels with urate-lowering therapy (ULT), such as allopurinol, is crucial for preventing flares and dissolving MSU crystals.
  • Initiating ULT requires careful dose titration and concurrent anti-inflammatory prophylaxis to mitigate flares.

Conclusions:

  • Long-term gout management necessitates consistent urate-lowering therapy to achieve therapeutic targets and prevent complications.
  • Integrated care models, particularly nurse-led interventions, significantly enhance patient adherence, education, and overall management effectiveness.
  • A multi-faceted approach combining pharmacotherapy and patient-centered care represents the current best practice for managing chronic gout.